The likely upside path is strong revenue growth plus multiple compression, not endless
rerating. If Cerebras converts signed demand into live cloud capacity, broadens beyond a few anchor customers, and shifts mix toward recurring
inference and assurance-style contracts, equity value can still compound well from here. The market already prices in relevance, so shareholder returns depend on conversion and utilization.